Publications in collaboration with researchers from Hospital Universitario La Paz (18)

2022

  1. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

    Translational Research, Vol. 230, pp. 68-81

  3. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

  4. sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies

    Frontiers in Neurology, Vol. 12

2020

  1. Sustained blood glutamate scavenging enhances protection in ischemic stroke

    Communications Biology, Vol. 3, Núm. 1

  2. Temperature-induced changes in reperfused stroke: Inflammatory and thrombolytic biomarkers

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-12

  3. The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 11, pp. 2103-2114

2015

  1. Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality

    Journal of Cerebral Blood Flow and Metabolism, Vol. 35, Núm. 7, pp. 1206-1212

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

2012

  1. Citicoline in the treatment of acute ischaemic stroke: An international, randomised, multicentre, placebo-controlled study (ICTUS trial)

    The Lancet, Vol. 380, Núm. 9839, pp. 349-357

2011

  1. Guía de recomendaciones en la aplicación de modelos animales para el estudio del ictus

    Neurologia, Vol. 26, Núm. 2, pp. 105-110

  2. Plan de asistencia sanitaria al ICTUS II. 2010

    Neurologia, Vol. 26, Núm. 7, pp. 383-396

2010

  1. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: How well are we correcting it?: Implications for outcome

    Stroke, Vol. 41, Núm. 10, pp. 2362-2365

2009

  1. Age determines the effects of blood pressure lowering during the acute phase of ischemic stroke: The TICA study

    Hypertension, Vol. 54, Núm. 4, pp. 769-774

  2. Response to letter by O'Connell et al

    Stroke

2005

  1. Headache in cerebral hemorrhage is associated with inflammatory markers and higher residual cavity

    Headache, Vol. 45, Núm. 9, pp. 1236-1243

2003

  1. Revisión de consenso. Neuroprotección farmacológica en la isquemia cerebral: ¿Es todavía una opción terapéutica?

    Neurologia, Vol. 18, Núm. 7, pp. 368-384